Alton; Kevin B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Alton; Kevin B..The latest application filed is for "process and device for response normalized liquid chromatography nanospray ionization mass spectrometry (rnlc-nsi-ms)".

Company Profile

0.5.11

Alton; Kevin B. - Cedar Knolls NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Piperazine derivatives useful as CCR5 antagonists Grant 7,825,121 - Ramanathan , et al. November 2, 2	2010-11-02
Process And Device For Response Normalized Liquid Chromatography Nanospray Ionization Mass Spectrometry (rnlc-nsi-ms) App 20080173808 - Ramanathan; Ragulan ; et al.	2008-07-24
Metabolite of xanthine Phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction Grant 7,312,223 - Ghosal , et al. December 25, 2	2007-12-25
Controlled-release formulation of HCV protease inhibitor and methods using the same App 20070237818 - Malcolm; Bruce A. ; et al.	2007-10-11
Medicaments and methods combining a HCV protease inhibitor and an AKR competitor App 20070232527 - Ghosal; Anima ; et al.	2007-10-04
Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases Grant 7,271,174 - Chowdhury , et al. September 18, 2	2007-09-18
Medicaments and methods combining a HCV protease inhibitor and an AKR competitor App 20070207949 - Ghosal; Anima ; et al.	2007-09-06
Ccr5 Antagonists Useful For Treating Hiv App 20070203149 - Ramanathan; Ragulan ; et al.	2007-08-30
Medicaments and methods combining a HCV protease inhibitor and an AKR competitor App 20060276404 - Ghosal; Anima ; et al.	2006-12-07
Piperazine derivatives useful as CCR5 antagonists App 20060105964 - Ramanathan; Ragulan ; et al.	2006-05-18
Substituted 2-azetidinones useful as hypocholesterolemic agents Grant 6,982,251 - Ghosal , et al. January 3, 2	2006-01-03
Metabolite of xanthine phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction App 20050026939 - Ghosal, Anima ; et al.	2005-02-03
Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases App 20040266810 - Chowdhury, Swapan K. ; et al.	2004-12-30
Substituted 2-azetidinones useful as hypocholesterolemic agents App 20030105028 - Ghosal, Anima ; et al.	2003-06-05
Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents App 20020137690 - Ghosal, Anima ; et al.	2002-09-26
Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents Grant 5,756,470 - Yumibe , et al. May 26, 1	1998-05-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.